Arvinas, Inc. (ARVN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arvinas, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.659 welcome each and every one of you to the Arvina's first quarter 2025 earnings call. 00:00:05.659 -- 00:00:09.565 All lines have been placed on mute to prevent any background noise. 00:00:09.565 -- 00:00:13.430 After the speaker's remarks, there will be a question and answer session. 00:00:13.430 -- 00:00:17.436 If you would like to ask a question during this time, simply press star followed by the 00:00:17.436 -- 00:00:22.463 number one on your telephone keypad. It is now my pleasure to turn today's call over 00:00:22.463 -- 00:00:26.569 to Arvina's Vice President of Investor Relations, Jeff Boyle. 00:00:26.569 -- 00:00:29.050 Please go ahead. 00:00:29.140 -- 00:00:32.526 Thank you, and good morning, everyone. Thanks for joining us. 00:00:32.526 -- 00:00:37.775 Earlier today, we issued a press release with our first quarter 2025 financial results, 00:00:37.775 -- 00:00:42.022 which is available in the investor and media section of our website at Arvinas.com. 00:00:42.022 -- 00:00:46.249 Joining the call today are John Houston, Arvinas' chief executive officer, president, 00:00:46.249 -- 00:00:51.317 and chairperson, Noah Berkowitz, our chief medical officer, and Andrew Saag, our chief 00:00:51.317 -- 00:00:56.299 financial officer. Our chief scientific officer, Andrew Saag, was scheduled to join us 00:00:56.299 -- 00:00:59.964 this morning, but had an unanticipated personal event and will not be able to. 00:00:59.964 -- 00:01:05.012 Before we begin the call, I'll remind you that today's discussion contains forward-looking 00:01:05.012 -- 00:01:08.497 statements that involve risks, uncertainties, and assumptions. 00:01:08.497 -- 00:01:12.343 These risks and uncertainties are outlined in today's press release and in the company's 00:...